Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cell adhesion molecule binding	ABCF3 CDHR3 TBC1D2 CDH23 ITGA2 IZUMO1R CNTN6 PTPRF DMD FLNA FN1 DSC2 EIF4H ICAM3 GRIN2A GRIN2B TENM4 TENM3 ICAM5 PKP3 CDH17	2.89e-07	599	190	21	GO:0050839
GeneOntologyMolecularFunction	proteoglycan binding	ITGA2 PTPRF FN1 COL5A3 CHRD	1.22e-04	51	190	5	GO:0043394
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	DCHS2 CDHR3 CEACAM7 CDH23 CNTN6 PTPRF DSC1 DSC2 PCDHGB7 PCDHGA9 PCDHGA1 PCDH20 TENM3 CDH17	2.32e-09	187	191	14	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	DCHS2 CDHR3 CEACAM7 CDH23 CNTN6 PTPRF DSC1 DSC2 PCDHGB7 PCDHGA9 PCDHGA1 PCDH20 TENM4 TENM3 CDH17	2.42e-07	313	191	15	GO:0098742
GeneOntologyBiologicalProcess	cell-cell adhesion	DCHS2 CDHR3 CEACAM7 IRAK1 CDH23 ITGA2 CNTN6 PTPRF GLI2 CCL2 ALOX5 FLNA DSC1 DSC2 PCDHGB7 PCDHGA9 PCDHGA1 ICAM3 RELA PCDH20 TENM4 TENM3 ICAM5 PKP3 NFAT5 CDH17	7.37e-06	1077	191	26	GO:0098609
GeneOntologyCellularComponent	desmosome	POF1B DSC1 DSC2 PKP3	1.19e-04	28	192	4	GO:0030057
Domain	Cadherin	DCHS2 CDHR3 CDH23 FREM2 DSC1 DSC2 PCDHGB7 PCDHGA9 PCDHGA1 FREM3 PCDH20 CDH17	2.41e-09	118	187	12	IPR002126
Domain	CA	DCHS2 CDHR3 CDH23 FREM2 DSC1 DSC2 PCDHGB7 PCDHGA9 PCDHGA1 PCDH20 CDH17	2.17e-08	115	187	11	SM00112
Domain	CADHERIN_1	DCHS2 CDHR3 CDH23 DSC1 DSC2 PCDHGB7 PCDHGA9 PCDHGA1 PCDH20 CDH17	2.02e-07	113	187	10	PS00232
Domain	Cadherin	DCHS2 CDHR3 CDH23 DSC1 DSC2 PCDHGB7 PCDHGA9 PCDHGA1 PCDH20 CDH17	2.02e-07	113	187	10	PF00028
Domain	CADHERIN_2	DCHS2 CDHR3 CDH23 DSC1 DSC2 PCDHGB7 PCDHGA9 PCDHGA1 PCDH20 CDH17	2.20e-07	114	187	10	PS50268
Domain	-	DCHS2 CDHR3 CDH23 DSC1 DSC2 PCDHGB7 PCDHGA9 PCDHGA1 PCDH20 CDH17	2.20e-07	114	187	10	2.60.40.60
Domain	Cadherin-like	DCHS2 CDHR3 CDH23 DSC1 DSC2 PCDHGB7 PCDHGA9 PCDHGA1 PCDH20 CDH17	2.59e-07	116	187	10	IPR015919
Domain	Cadherin_CS	DCHS2 CDH23 DSC1 DSC2 PCDHGB7 PCDHGA9 PCDHGA1 PCDH20 CDH17	1.50e-06	109	187	9	IPR020894
Domain	Rhs_assc_core	TENM4 TENM3	2.97e-04	3	187	2	IPR022385
Domain	BAT2_N	PRRC2C PRRC2B	2.97e-04	3	187	2	PF07001
Domain	NMDAR2_C	GRIN2A GRIN2B	2.97e-04	3	187	2	PF10565
Domain	BAT2_N	PRRC2C PRRC2B	2.97e-04	3	187	2	IPR009738
Domain	NMDAR2_C	GRIN2A GRIN2B	2.97e-04	3	187	2	IPR018884
Domain	PRRC2	PRRC2C PRRC2B	2.97e-04	3	187	2	IPR033184
Domain	CX3CL1	CCL2 CCL13	5.90e-04	4	187	2	IPR008097
Domain	Tox-GHH_dom	TENM4 TENM3	5.90e-04	4	187	2	IPR028916
Domain	Tox-GHH	TENM4 TENM3	5.90e-04	4	187	2	PF15636
Domain	MeTrfase	METTL2A METTL2B	5.90e-04	4	187	2	IPR026113
Domain	ICAM	ICAM3 ICAM5	5.90e-04	4	187	2	IPR003988
Domain	Ten_N	TENM4 TENM3	5.90e-04	4	187	2	IPR009471
Domain	Ten_N	TENM4 TENM3	5.90e-04	4	187	2	PF06484
Domain	TENEURIN_N	TENM4 TENM3	5.90e-04	4	187	2	PS51361
Domain	CarboxyPept-like_regulatory	CPM TENM4 TENM3	6.06e-04	17	187	3	IPR008969
Domain	ICAM_N	ICAM3 ICAM5	9.78e-04	5	187	2	PF03921
Domain	YD	TENM4 TENM3	9.78e-04	5	187	2	IPR006530
Domain	ICAM_N	ICAM3 ICAM5	9.78e-04	5	187	2	IPR013768
Pathway	WP_IL1_SIGNALING	IRAK1 TAB2 ECSIT JUN CCL2 RELA	1.00e-05	55	128	6	M39346
Pathway	REACTOME_CHL1_INTERACTIONS	ITGA2 CNTN6 NRP1	5.90e-05	9	128	3	M27379
Pathway	BIOCARTA_TOLL_PATHWAY	IRAK1 ECSIT JUN RELA	5.99e-05	24	128	4	MM1518
Pubmed	Human transcription factor protein interaction networks.	ZHX3 LRRC49 MAML1 IRAK1 ZNF462 KMT2C JUN CPSF4 PRRC2C GLI2 RECQL5 NFYC HELZ DYNC1H1 PRRC2B HSPG2 ZBTB33 EP400 NACC1 DDX52 POU2F1 DDX56 RELA SIN3A MORC4 TADA1 ZFHX4 CCAR1 AGK PUM1 CNOT1 PYGO1	2.36e-11	1429	195	32	35140242
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	SP4 SPATA31E1 TULP4 GLI2 FHIP1A DYNC1H1 MAGEL2 UBQLN1 IPO7 EP400 SIN3A MAU2 PKNOX2 USF3 ZMYM5	2.47e-08	430	195	15	35044719
Pubmed	Protein interactome mining defines melatonin MT1 receptors as integral component of presynaptic protein complexes of neurons.	HIVEP2 UBQLN4 SREBF1 NEB KMT2C DMD DYNC1H1 FLNA UBQLN1 FN1 DDX52 MAMLD1 TENM3	4.02e-08	322	195	13	26514267
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	ABCF3 MAML1 QRICH1 JUN PRRC2C AGL A2ML1 NFYC DYNC1H1 UBR2 ZBTB33 EP400 NACC1 RBL2 DDX52 POU2F1 RELA SIN3A ZFHX4 PUM1	9.06e-08	857	195	20	25609649
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	LRRC49 UBQLN4 IRAK1 ZNF462 BRCA2 FLNA ZBTB33 RPAP3 NACC1 ZDBF2 MORC4 ZFHX4 CNOT1 ZMYM5	1.20e-07	418	195	14	34709266
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	ZHX3 HIVEP2 ZBTB20 ZNF174 SREBF1 QRICH1 ZNF462 KMT2C JUN CPSF4 GLI2 ZBTB33 EIF4H POU2F1 PKNOX2 GTF2A1 NFAT5 PYGO1	1.20e-07	709	195	18	22988430
Pubmed	A human MAP kinase interactome.	HIVEP2 NEB KMT2C JUN TSC22D1 NFYC HELZ DMD FLNA RELA MSL2 GTF2A1 USF3 HERPUD1 PYGO1	1.21e-07	486	195	15	20936779
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	HIVEP2 SREBF1 MAML1 IRAK1 KMT2C JUN PTPRF TULP4 ALOX5 DYNC1H1 PRRC2B HSPG2 FLNA EP400 DDX56 RASSF7 ORC1 INTS5 C2CD3 PCNX1 MAPKBP1 PUM1	3.07e-07	1105	195	22	35748872
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	UBQLN4 DAD1 IRAK1 QRICH1 PLD3 ECSIT NRSN2 PTPRF CEP78 DYNC1H1 SEC23A FLNA UBQLN1 IPO7 DSC2 DDX52 RNF126 INTS5 PUM1 HERPUD1	4.05e-07	942	195	20	31073040
Pubmed	Tagging genes with cassette-exchange sites.	QRICH1 ZNF462 KMT2C CPSF4 PRRC2C GLI2 HELZ EIF4H DDX56 ENAH PUM1 REXO1L1P	4.86e-07	335	195	12	15741177
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ZHX3 PRRC2C DYNC1H1 PRRC2B UBR2 IQSEC3 EP400 EIF4H TENM4 TENM3 MAPKBP1 PUM1 NFAT5	5.88e-07	407	195	13	12693553
Pubmed	Specificity protein 4 functionally regulates the transcription of NMDA receptor subunits GluN1, GluN2A, and GluN2B.	SP4 GRIN2A GRIN2B	6.91e-07	4	195	3	23871830
Pubmed	Herp enhances ER-associated protein degradation by recruiting ubiquilins.	UBQLN4 UBQLN1 HERPUD1	6.91e-07	4	195	3	18307982
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	ZHX3 SP4 ZBTB20 SREBF1 ZNF462 JUN TSC22D1 CPSF4 ZNF347 NFYC ZBTB33 POU2F1 RELA GTF2A1 CCAR1 NFAT5 ZMYM5 MYBL1	8.03e-07	808	195	18	20412781
Pubmed	A census of human transcription factors: function, expression and evolution.	ZHX3 SP4 HIVEP2 ZNF174 SREBF1 JUN TSC22D1 NKX6-3 GLI2 NFYC NPAS1 ZBTB33 POU2F1 RELA PKNOX2 USF3 ZFHX4 NFAT5 MYBL1	9.95e-07	908	195	19	19274049
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	ZHX3 SP4 ZNF174 MAML1 QRICH1 KMT2C JUN PRRC2C SEPTIN14 DYNC1H1 PRRC2B FLNA UBQLN1 IPO7 EP400 EIF4H NACC1 POU2F1 SIN3A CCAR1 CNOT1	1.18e-06	1103	195	21	34189442
Pubmed	c-Jun controls histone modifications, NF-kappaB recruitment, and RNA polymerase II function to activate the ccl2 gene.	JUN CCL2 RELA	1.72e-06	5	195	3	18443042
Pubmed	A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.	ZNF462 KMT2C BRCA2 EP400 NACC1 SIN3A PUM1 CNOT1	1.84e-06	146	195	8	23892456
Pubmed	Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling.	FREM2 PTPRF DYNC1H1 DSC2 PCDH20 AGK	2.16e-06	67	195	6	21875946
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	CCP110 POF1B ZNF462 KMT2C CPSF4 PRRC2C IPO7 EP400 NACC1 SIN3A MORC4 CCAR1 CNOT1	2.82e-06	469	195	13	27634302
Pubmed	Herpesvirus tegument protein activates NF-kappaB signaling through the TRAF6 adaptor protein.	IRAK1 TAB2 RELA	3.43e-06	6	195	3	18682563
Pubmed	HIV-Tat protein induces oxidative and inflammatory pathways in brain endothelium.	JUN CCL2 RELA	3.43e-06	6	195	3	12485413
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CCP110 ZNF462 TSC22D1 TULP4 ZNF347 FAM135A ZFC3H1 ATP10A MSL2 USF3 GLCE REXO1L1P HERPUD1	4.84e-06	493	195	13	15368895
Pubmed	Downregulation of integrins by von Hippel-Lindau (VHL) tumor suppressor protein is independent of VHL-directed hypoxia-inducible factor alpha degradation.	ITGA2 VHL FN1	5.98e-06	7	195	3	18523483
Pubmed	Brain endothelial miR-146a negatively modulates T-cell adhesion through repressing multiple targets to inhibit NF-κB activation.	IRAK1 RELA NFAT5	5.98e-06	7	195	3	25515214
Pubmed	The human immunodeficiency virus type 1 Tat protein up-regulates the promoter activity of the beta-chemokine monocyte chemoattractant protein 1 in the human astrocytoma cell line U-87 MG: role of SP-1, AP-1, and NF-kappaB consensus sites.	JUN CCL2 RELA	5.98e-06	7	195	3	10644332
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	CCP110 MAML1 IRAK1 TAB2 CPSF4 CEP78 OSCP1 DMD SEC23A MOCOS RPAP3 NACC1 DDX56 RELA RASSF7 PKP3 ENAH PUM1 CNOT1	6.87e-06	1038	195	19	26673895
Pubmed	Functional proteomics mapping of a human signaling pathway.	UBQLN4 QRICH1 PTPRF DYNC1H1 VHL HSPG2 FLNA UBQLN1 FN1 MORC4 TENM3 CCDC181 PUM1 ZMYM5	7.06e-06	591	195	14	15231748
Pubmed	3D Mapping Reveals a Complex and Transient Interstitial Matrix During Murine Kidney Development.	FREM2 HSPG2 COL5A3	9.52e-06	8	195	3	33875569
Pubmed	In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor.	JUN POU2F1 RELA	9.52e-06	8	195	3	7690421
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	HIVEP2 ZBTB20 PLD3 ITPK1 NRP1 ZNF462 KMT2C TSC22D1 TULP4 GLI2 MOCOS UBR2 FRMPD2 DYNC2I1 DDX56 ATP10A PKNOX2 USF3 PKP3 ENAH CCAR1 NFAT5 CNOT1	1.15e-05	1489	195	23	28611215
Pubmed	Genome-wide association study of smoking initiation and current smoking.	CDH23 GRIN2A GRIN2B	1.42e-05	9	195	3	19268276
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	IRAK1 KMT2C PRRC2C DYNC1H1 PRRC2B FLNA ZBTB33 EP400 RPAP3 SIN3A ICAM5 ENAH CNOT1	1.52e-05	549	195	13	38280479
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	PTGDS NRP1 FREM2 FCGBP PTPRF HSPG2 FN1 DSC2 ICAM3	1.61e-05	257	195	9	16335952
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	ZHX3 MAML1 TAB2 NEB PRRC2B VHL MXRA5 IPO7 NACC1 ZDBF2 MORC4 AGK CNOT1 CDH17	1.66e-05	638	195	14	31182584
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	ZHX3 MAML1 IRAK1 KMT2C NFYC SEC23A IPO7 EP400 RBL2 MORC4 ZFHX4	1.71e-05	398	195	11	35016035
Pubmed	Ring finger protein20 regulates hepatic lipid metabolism through protein kinase A-dependent sterol regulatory element binding protein1c degradation.	SREBF1 NACC1 CCAR1	2.02e-05	10	195	3	24425205
Pubmed	The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis.	FREM2 COL5A3 FREM3	2.02e-05	10	195	3	15345741
Pubmed	Oct4 links multiple epigenetic pathways to the pluripotency network.	GLI2 HELZ DYNC1H1 PRRC2B HSPG2 FLNA NACC1 CNOT1	2.07e-05	203	195	8	22083510
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	ZHX3 MAML1 JUN CPSF4 PRRC2B ZBTB33 EP400 SIN3A MORC4	2.24e-05	268	195	9	33640491
Pubmed	Discovery and refinement of loci associated with lipid levels.	ABCA1 GCKR BRCA2 A2ML1 ALOX5 FN1 CUBN MSL2	2.73e-05	211	195	8	24097068
Pubmed	Dominant-negative inhibition of Ca2+ influx via TRPV2 ameliorates muscular dystrophy in animal models.	TRPV2 DMD	3.13e-05	2	195	2	19050039
Pubmed	Stretch-induced activation of the transcription factor activator protein-1 controls monocyte chemoattractant protein-1 expression during arteriogenesis.	JUN CCL2	3.13e-05	2	195	2	18669921
Pubmed	Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms.	GRIN2A GRIN2B	3.13e-05	2	195	2	20921396
Pubmed	The GRIN2B and GRIN2A Gene Variants Are Associated With Continuous Performance Test Variables in ADHD.	GRIN2A GRIN2B	3.13e-05	2	195	2	27199241
Pubmed	NMDA receptor subunit composition determines beta-amyloid-induced neurodegeneration and synaptic loss.	GRIN2A GRIN2B	3.13e-05	2	195	2	23618906
Pubmed	Both NR2A and NR2B subunits of the NMDA receptor are critical for long-term potentiation and long-term depression in the lateral amygdala of horizontal slices of adult mice.	GRIN2A GRIN2B	3.13e-05	2	195	2	19474217
Pubmed	Lack of NMDA receptor subtype selectivity for hippocampal long-term potentiation.	GRIN2A GRIN2B	3.13e-05	2	195	2	16033900
Pubmed	5-Lipoxygenase compartmentalization in granulocytic cells is modulated by an internal bipartite nuclear localizing sequence and nuclear factor kappa B complex formation.	ALOX5 RELA	3.13e-05	2	195	2	9681993
Pubmed	Effects of GluN2A and GluN2B gain-of-function epilepsy mutations on synaptic currents mediated by diheteromeric and triheteromeric NMDA receptors.	GRIN2A GRIN2B	3.13e-05	2	195	2	32247039
Pubmed	The Developmental Shift of NMDA Receptor Composition Proceeds Independently of GluN2 Subunit-Specific GluN2 C-Terminal Sequences.	GRIN2A GRIN2B	3.13e-05	2	195	2	30355491
Pubmed	Roles of NMDA receptor NR2A and NR2B subtypes for long-term depression in the anterior cingulate cortex.	GRIN2A GRIN2B	3.13e-05	2	195	2	16045501
Pubmed	Endonuclease V Regulates Atherosclerosis Through C-C Motif Chemokine Ligand 2-Mediated Monocyte Infiltration.	CDH23 CCL2	3.13e-05	2	195	2	34259011
Pubmed	NR2A- and NR2B-NMDA receptors and drebrin within postsynaptic spines of the hippocampus correlate with hunger-evoked exercise.	GRIN2A GRIN2B	3.13e-05	2	195	2	27915379
Pubmed	Plakophilin3 increases desmosome assembly, size and stability by increasing expression of desmocollin2.	DSC2 PKP3	3.13e-05	2	195	2	29146182
Pubmed	Hepatitis C virus core+1/ARF protein decreases hepcidin transcription through an AP1 binding site.	JUN HAMP	3.13e-05	2	195	2	23580428
Pubmed	Chuvash polycythemia VHLR200W mutation is associated with down-regulation of hepcidin expression.	VHL HAMP	3.13e-05	2	195	2	21876117
Pubmed	Virally mediated knock-down of NR2 subunits ipsilateral to the deprived eye blocks ocular dominance plasticity.	GRIN2A GRIN2B	3.13e-05	2	195	2	16944113
Pubmed	Dystrophic cardiomyopathy: role of TRPV2 channels in stretch-induced cell damage.	TRPV2 DMD	3.13e-05	2	195	2	25616416
Pubmed	Brain-region-specific changes in neurons and glia and dysregulation of dopamine signaling in Grin2a mutant mice.	GRIN2A GRIN2B	3.13e-05	2	195	2	37657442
Pubmed	Transcription Factor NFAT5 Promotes Migration and Invasion of Rheumatoid Synoviocytes via Coagulation Factor III and CCL2.	CCL2 NFAT5	3.13e-05	2	195	2	29794013
Pubmed	Individual NMDA receptor GluN2 subunit signaling domains differentially regulate the postnatal maturation of hippocampal excitatory synaptic transmission and plasticity but not dendritic morphology.	GRIN2A GRIN2B	3.13e-05	2	195	2	38813758
Pubmed	Age-Dependent Changes in Synaptic NMDA Receptor Composition in Adult Human Cortical Neurons.	GRIN2A GRIN2B	3.13e-05	2	195	2	32191258
Pubmed	Neuropilin-1 contributes to esophageal squamous cancer progression via promoting P65-dependent cell proliferation.	NRP1 RELA	3.13e-05	2	195	2	29059172
Pubmed	The second PDZ domain of scaffold protein Frmpd2 binds to GluN2A of NMDA receptors.	FRMPD2 GRIN2A	3.13e-05	2	195	2	31196628
Pubmed	Hydrogen sulfide suppresses oxidized low-density lipoprotein (ox-LDL)-stimulated monocyte chemoattractant protein 1 generation from macrophages via the nuclear factor κB (NF-κB) pathway.	CCL2 RELA	3.13e-05	2	195	2	24550391
Pubmed	Chronic early postnatal scream sound stress induces learning deficits and NMDA receptor changes in the hippocampus of adult mice.	GRIN2A GRIN2B	3.13e-05	2	195	2	27015584
Pubmed	Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterations.	CCL2 HAMP	3.13e-05	2	195	2	21183736
Pubmed	Directional gating of synaptic plasticity by GPCRs and their distinct downstream signalling pathways.	GRIN2A GRIN2B	3.13e-05	2	195	2	22334046
Pubmed	Role of N-methyl-d-aspartate receptor subunits GluN2A and GluN2B in auditory thalamocortical long-term potentiation in adult mice.	GRIN2A GRIN2B	3.13e-05	2	195	2	34197904
Pubmed	Roles of NMDA NR2B subtype receptor in prefrontal long-term potentiation and contextual fear memory.	GRIN2A GRIN2B	3.13e-05	2	195	2	16157280
Pubmed	N-Methyl-d-aspartic Acid (NMDA) Receptor Is Involved in the Inhibitory Effect of Ketamine on Human Sperm Functions.	GRIN2A GRIN2B	3.13e-05	2	195	2	34830255
Pubmed	The cytoplasmic domain of neuropilin-1 regulates focal adhesion turnover.	NRP1 FLNA	3.13e-05	2	195	2	24021649
Pubmed	Evolution of GluN2A/B cytoplasmic domains diversified vertebrate synaptic plasticity and behavior.	GRIN2A GRIN2B	3.13e-05	2	195	2	23201971
Pubmed	Mechanistic Insight into NMDA Receptor Dysregulation by Rare Variants in the GluN2A and GluN2B Agonist Binding Domains.	GRIN2A GRIN2B	3.13e-05	2	195	2	27839871
Pubmed	Metaplasticity gated through differential regulation of GluN2A versus GluN2B receptors by Src family kinases.	GRIN2A GRIN2B	3.13e-05	2	195	2	22187052
Pubmed	NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner.	GRIN2A GRIN2B	3.13e-05	2	195	2	17569088
Pubmed	Altered effects of ethanol in NR2A(DeltaC/DeltaC) mice expressing C-terminally truncated NR2A subunit of NMDA receptor.	GRIN2A GRIN2B	3.13e-05	2	195	2	11530236
Pubmed	The glutamate receptor GluN2 subunit regulates synaptic trafficking of AMPA receptors in the neonatal mouse brain.	GRIN2A GRIN2B	3.13e-05	2	195	2	25131300
Pubmed	The role of NMDAR subtypes and charge transfer during hippocampal LTP induction.	GRIN2A GRIN2B	3.13e-05	2	195	2	16901514
Pubmed	Specific involvement of postsynaptic GluN2B-containing NMDA receptors in the developmental elimination of corticospinal synapses.	GRIN2A GRIN2B	3.13e-05	2	195	2	20696923
Pubmed	Teneurins assemble into presynaptic nanoclusters that promote synapse formation via postsynaptic non-teneurin ligands.	TENM4 TENM3	3.13e-05	2	195	2	35484136
Pubmed	Importance of the GluN2B carboxy-terminal domain for enhancement of social memories.	GRIN2A GRIN2B	3.13e-05	2	195	2	26179233
Pubmed	Disease-associated nonsense and frame-shift variants resulting in the truncation of the GluN2A or GluN2B C-terminal domain decrease NMDAR surface expression and reduce potentiating effects of neurosteroids.	GRIN2A GRIN2B	3.13e-05	2	195	2	38214768
Pubmed	Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-κB.	EIF4H RELA	3.13e-05	2	195	2	23776612
Pubmed	[Different distribution of NMDA receptor subunits in cortex contributes to selective vulnerability of motor neurons in amyotrophic lateral sclerosis].	GRIN2A GRIN2B	3.13e-05	2	195	2	21503117
Pubmed	Functional contributions of synaptically localized NR2B subunits of the NMDA receptor to synaptic transmission and long-term potentiation in the adult mouse CNS.	GRIN2A GRIN2B	3.13e-05	2	195	2	18372311
Pubmed	A study of hepcidin and monocyte chemoattractant protein-1 in Egyptian females with systemic lupus erythematosus.	CCL2 HAMP	3.13e-05	2	195	2	24578220
Pubmed	Differential deposition of basement membrane components during formation of the caudal neural tube in the mouse embryo.	HSPG2 FN1	3.13e-05	2	195	2	3665768
Pubmed	Separate functional properties of NMDARs regulate distinct aspects of spatial cognition.	GRIN2A GRIN2B	3.13e-05	2	195	2	29764972
Pubmed	Increasing the GluN2A/GluN2B Ratio in Neurons of the Mouse Basal and Lateral Amygdala Inhibits the Modification of an Existing Fear Memory Trace.	GRIN2A GRIN2B	3.13e-05	2	195	2	27605622
Pubmed	Disease-associated GRIN protein truncating variants trigger NMDA receptor loss-of-function.	GRIN2A GRIN2B	3.13e-05	2	195	2	33043365
Pubmed	N-methyl-D-aspartate receptor subunit NR2A and NR2B messenger RNA levels are altered in the hippocampus and entorhinal cortex in Alzheimer's disease.	GRIN2A GRIN2B	3.13e-05	2	195	2	12127670
Pubmed	Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes.	GRIN2A GRIN2B	3.13e-05	2	195	2	20890276
Pubmed	Inhibition of prostaglandin D synthase suppresses muscular necrosis.	PTGDS DMD	3.13e-05	2	195	2	19359520
Pubmed	Effects of mycophenolate mofetil on the expression of monocyte chemoattractant protein-1 and fibronectin in high glucose cultured human mesangial cells.	CCL2 FN1	3.13e-05	2	195	2	24782172
Pubmed	Lupus autoantibodies act as positive allosteric modulators at GluN2A-containing NMDA receptors and impair spatial memory.	GRIN2A GRIN2B	3.13e-05	2	195	2	32179753
Pubmed	Elevated levels of FN1 and CCL2 in bronchoalveolar lavage fluid from sarcoidosis patients.	CCL2 FN1	3.13e-05	2	195	2	27259755
Pubmed	Attenuation of focal ischemic brain injury in mice deficient in the epsilon1 (NR2A) subunit of NMDA receptor.	GRIN2A GRIN2B	3.13e-05	2	195	2	9822733
Pubmed	Essential role of TRPV2 ion channel in the sensitivity of dystrophic muscle to eccentric contractions.	TRPV2 DMD	3.13e-05	2	195	2	19840792
GeneFamily	Cadherin related	DCHS2 CDHR3 CDH23	1.77e-04	17	119	3	24
GeneFamily	Ubiquilin family	UBQLN4 UBQLN1	4.24e-04	5	119	2	783
GeneFamily	Desmosomal cadherins	DSC1 DSC2	8.83e-04	7	119	2	1188
GeneFamily	Glutamate ionotropic receptor NMDA type subunits	GRIN2A GRIN2B	8.83e-04	7	119	2	1201
GeneFamily	Protein arginine methyltransferases	PRMT9 PRMT2	1.50e-03	9	119	2	691
GeneFamily	Immunoglobulin like domain containing	CEACAM7 VSIG1 HSPG2 MXRA5 ICAM3 ICAM5	1.75e-03	193	119	6	594
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#5	ABCA1 CELF4 ZBTB20 GPR50 IRAK1 PLD3 NEB CNTN6 ZNF462 NRSN2 TULP4 DMD MAGEL2 RBL2 MAMLD1 ZDBF2 C2CD3 TADA1 MAPKBP1 PYGO1	3.32e-06	688	188	20	Facebase_RNAseq_e10.5_Mandibular Arch_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#2	CCP110 SP4 ABCA1 CELF4 ZBTB20 GPR50 PLD3 NEB CNTN6 NRSN2 TULP4 MED12L DMD RBL2 MAMLD1 C2CD3 TADA1 MAPKBP1 PYGO1	6.66e-06	659	188	19	Facebase_RNAseq_e10.5_Olfactory Pit_2500_K2
CoexpressionAtlas	FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#3	ABCA1 CELF4 ZBTB20 GPR50 IRAK1 PLD3 NEB CNTN6 KMT2C NRSN2 TULP4 MED12L DMD VHL RBL2 MAMLD1 C2CD3 TADA1 MAPKBP1 PYGO1	8.00e-06	730	188	20	Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K3
CoexpressionAtlas	FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2	RFK ABCA1 CELF4 ZBTB20 GPR50 IRAK1 PLD3 NEB CNTN6 KMT2C NRSN2 TULP4 MED12L DMD VHL RBL2 MAMLD1 C2CD3 TADA1 MAPKBP1	1.12e-05	747	188	20	Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K2
CoexpressionAtlas	FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#5	ABCA1 CELF4 ZBTB20 GPR50 IRAK1 PLD3 NEB CNTN6 KMT2C NRSN2 TULP4 DMD VHL RBL2 MAMLD1 C2CD3 TADA1 MAPKBP1 PYGO1	2.38e-05	722	188	19	Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K5
CoexpressionAtlas	Sex-Associated_Pluripotency-Differentiation-fold2.0_adjp0.05	GPR50 NEB PTGDS FCGBP PXDNL TRPV2 MAGEB17 MXRA5 MAMLD1 GOLGA6D DYNC2I1 DUSP15 MORC4 ATP10A PKP3 PYGO1	3.16e-05	548	188	16	PCBC_ratio_Sex-Associated_Pluripotency-Differentiation-2X-p05
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5	ABCA1 CELF4 ZBTB20 GPR50 IRAK1 PLD3 NEB CNTN6 KMT2C NRSN2 TULP4 DMD VHL RBL2 MAMLD1 C2CD3 TADA1 MAPKBP1 PYGO1	3.51e-05	743	188	19	Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K5
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4	ABCA1 CELF4 ZBTB20 GPR50 IRAK1 PLD3 NEB CNTN6 KMT2C NRSN2 TULP4 DMD VHL RBL2 MAMLD1 C2CD3 TADA1 MAPKBP1	7.73e-05	721	188	18	Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K4
CoexpressionAtlas	FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5	ABCA1 CELF4 ZBTB20 GPR50 IRAK1 PLD3 NEB CNTN6 NRSN2 TULP4 DMD RBL2 MAMLD1 C2CD3 TADA1 MAPKBP1 CCDC181	8.14e-05	658	188	17	Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	ABCA1 CELF4 ZBTB20 GPR50 PLD3 NEB CNTN6 NRSN2 TULP4 DMD RBL2 MAMLD1 C2CD3 TADA1 MAPKBP1 PYGO1	1.20e-04	614	188	16	Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#2	ABCA1 CELF4 ZBTB20 GPR50 IRAK1 PLD3 NEB CNTN6 KMT2C NRSN2 TULP4 DMD RBL2 MAMLD1 C2CD3 TADA1 MAPKBP1 PYGO1	1.21e-04	747	188	18	Facebase_RNAseq_e9.5_Maxillary Arch_2500_K2
ToppCell	wk_20-22-Epithelial-PNS-intermediate_Schwann\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	TAB2 CNTN6 ITPK1 DMD HSPG2 MAMLD1 GRIN2B C17orf113 TENM3 KIAA1755	8.79e-09	184	194	10	4e3ba64692868563a579902aa9c6f88cab5bce26
ToppCell	wk_15-18-Epithelial-Distal_epithelial-type_II_pneumocyte\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	TBC1D2 PLD3 FREM2 PTPRF DMD HSPG2 CPM FREM3 RASSF7 PKP3	1.53e-08	195	194	10	0e3aac1b1a1fd483f5fb9a394eb90c0e1ce63542
ToppCell	droplet-Lung-30m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l33\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZHX3 UBQLN4 PTGDS CTTNBP2NL COL5A3 INTS5 GLCE MAPKBP1	1.52e-07	136	194	8	a43b3db1754c619d328a26a2ba6af4756629a723
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GLI2 DMD FLNA FN1 ATP10A PKNOX2 ZFHX4 TENM3 ENAH	2.00e-07	195	194	9	dd281a249854800f737dc22e0f375f66dfb5cf5f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GLI2 DMD FLNA FN1 ATP10A PKNOX2 ZFHX4 TENM3 ENAH	2.00e-07	195	194	9	49c99553629cdd83ee56a2e508d5bc8d34b8507b
ToppCell	wk_20-22-Epithelial-Distal_epithelial-type_I_pneumocyte\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	TBC1D2 CNTN6 FREM2 ODAM DMD CPM FREM3 RASSF7 ICAM5	2.09e-07	196	194	9	e24a7aaf41793abba66c1189d933ca05b14c1af9
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GLI2 CCL2 DMD FN1 MAMLD1 COL5A3 TENM3 ENAH KIAA1755	2.18e-07	197	194	9	85a8f1d18e0dd1d31341f5131eecd217553bf042
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GLI2 CCL2 DMD FN1 MAMLD1 COL5A3 TENM3 ENAH KIAA1755	2.18e-07	197	194	9	e8e3ba791dfaa0fab35e0329a5e34376f9ee6143
ToppCell	Int-URO-Myeloid-tDC\|Int-URO / Disease, Lineage and Cell Type	PTGDS NRP1 MED12L OSCP1 HSPG2 OVOS2 HAMP HERPUD1	6.66e-07	165	194	8	9803c3db6cdcf925bea7d9c382bf4fd05acf3509
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GLI2 CCL2 DMD HSPG2 MAMLD1 TENM3 ICAM5 PYGO1	8.72e-07	171	194	8	972fab891135bd755d5526cbc5a963200067b0a6
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GLI2 CCL2 DMD HSPG2 MAMLD1 TENM3 ICAM5 PYGO1	8.72e-07	171	194	8	2a77ed79c6f2e700e789c80451a70ecb31639719
ToppCell	pdx-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	HIVEP2 ITGA2 NRP1 ZNF462 CPM GRIN2B ATP10A ZFHX4	1.39e-06	182	194	8	7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee
ToppCell	COVID-19-kidney-Fibroblast-1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NRP1 GLI2 DMD MAMLD1 ZDBF2 GRIN2A ZFHX4 TENM3	1.71e-06	187	194	8	76bfe8c42430a230a8bdf299575c444fb7780f24
ToppCell	PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	TBC1D2 CNTN6 FREM2 FCGBP PTPRF DMD FHIP1A CPM	1.78e-06	188	194	8	0d86044bc340e3efb90d0022dd299873639d831c
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ABCA1 NRP1 CCL2 FN1 MAMLD1 PKNOX2 TENM3 ENAH	2.00e-06	191	194	8	08720998aa55131d7377c4c67c4c935865bd7d79
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_satellite_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZHX3 ZBTB20 PRRC2C DMD IQSEC3 OPA3 ZDBF2 TENM4	2.16e-06	193	194	8	1aa3ab528605dc7b2fec46e759c9d1ee93d59b11
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	PTGDS GLI2 CCL2 MXRA5 FN1 TENM4 TENM3 ENAH	2.24e-06	194	194	8	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical\|TCGA-Thryoid / Sample_Type by Project: Shred V9	TBC1D2 SREBF1 ITGA2 PTPRF FN1 DDX52 MAMLD1 ICAM5	2.24e-06	194	194	8	b46c54802b8d1e0a0a17f9ed8e82eaf5e7f4849d
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZHX3 ZBTB20 PRRC2C DMD IPO7 RELA TENM4 PUM1	2.51e-06	197	194	8	5bc11aff92da2a0aca8473f997fe7a99f3cae75d
ToppCell	wk_15-18-Epithelial-Distal_epithelial\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CELF4 PLD3 FREM2 PTPRF DMD CPM RASSF7 PKP3	2.51e-06	197	194	8	b7aff83c27606d87565382a768119a863fe1c294
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	CDH23 ITGA2 PTGDS NRP1 FN1 TENM4 TENM3 ENAH	2.51e-06	197	194	8	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	15-Distal-Epithelial-Bud_tip_adjacent\|Distal / Age, Tissue, Lineage and Cell class	TBC1D2 FREM2 PTPRF ODAM DMD CPM RASSF7 PKP3	2.61e-06	198	194	8	f4d9d5995a42f71bf412f0ad299fc963bad3a898
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ITGA2 CNTN6 PTPRF MOCOS HSPG2 FREM3 ICAM5 PKP3	2.61e-06	198	194	8	b598ab958e31f1e98bd06dc0097b58ac3a3f90a3
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CDH23 ITGA2 LXN GLI2 FN1 PKNOX2 TENM3 ENAH	2.61e-06	198	194	8	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	wk_08-11-Epithelial-Airway_epithelial_progenitor\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	TBC1D2 PLD3 FREM2 PTPRF DMD CPM RASSF7 PKP3	2.71e-06	199	194	8	af664e0d41a889a75dbf6cf0d50acd26f5ab3a3a
ToppCell	COVID-19-kidney-Fibroblast-1\|kidney / Disease (COVID-19 only), tissue and cell type	ABCA1 NRP1 GLI2 DMD FN1 MAMLD1 GRIN2A TENM3	2.71e-06	199	194	8	9503646ff1ad248181146ce767e9d12e882ec3bd
ToppCell	tumor_Lung-Myeloid_cells-mo-Mac\|Myeloid_cells / Location, Cell class and cell subclass	ABCA1 PLD3 NRP1 JUN CCL2 CCL13 CPM HAMP	2.81e-06	200	194	8	58ff8db0ecf71daa86f9a38208e0d9b712cac0b5
ToppCell	tumor_Lymph_Node_/_Brain-Myeloid_cells-mo-Mac\|Myeloid_cells / Location, Cell class and cell subclass	ABCA1 PLD3 NRP1 JUN CCL2 CCL13 FN1 CPM	2.81e-06	200	194	8	195862a319794e57f0506757ae45ab70200bc5b4
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GCKR NRP1 GLI2 DMD COL5A3 GRIN2A TENM3	7.51e-06	163	194	7	8e32b6431e1862572663aa6ddc4ea299c6acc8a6
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GCKR NRP1 GLI2 DMD COL5A3 GRIN2A TENM3	7.51e-06	163	194	7	bbc078761c5043af13d9a6fcf3145a3e300bae5e
ToppCell	343B-Fibroblasts-Fibroblast-B_(Myofibroblast)\|343B / Donor, Lineage, Cell class and subclass (all cells)	ABCF3 MXRA5 PCDHGB7 MAMLD1 DUSP15 PKNOX2 TENM3	1.28e-05	177	194	7	e55d21d4d61a069b9bbe0e7595fbfb7cfbacfd87
ToppCell	facs-Thymus-Epithelium-3m-Myeloid-macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUN LY86 FHIP1A CPM CUBN ZXDB SRPK3	1.28e-05	177	194	7	384f841aa7b2d05815af7885e481f5affc55d897
ToppCell	facs-Thymus-Epithelium-3m-Myeloid\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUN LY86 FHIP1A CPM CUBN ZXDB SRPK3	1.28e-05	177	194	7	0e9e44119653abfd270e602e5e477a15e774638f
ToppCell	facs-Thymus-Epithelium-3m-Myeloid-macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUN LY86 FHIP1A CPM CUBN ZXDB SRPK3	1.28e-05	177	194	7	c2b8a3a149d70f77612759dea34df9e43953c566
ToppCell	343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	ABCF3 MXRA5 PCDHGB7 MAMLD1 DUSP15 PKNOX2 TENM3	1.28e-05	177	194	7	43ba6f12c2fb32698a420bf799d46ac1b558f146
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZNF462 HSPG2 ZBTB33 COL5A3 PCDH20 TENM3 ENAH	1.28e-05	177	194	7	6b4fe717928814dafcd13090b1c90ea973938c6d
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PLD3 NRP1 TRPV2 ALOX5 FLNA FN1 ATP10A	1.33e-05	178	194	7	0b398656f26c4061b11ccf98908d0e2e1367585a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NRP1 GLI2 CCL13 DMD GRIN2A ZFHX4 TENM3	1.33e-05	178	194	7	78a0c6340001a77f5b2d890b6263f574af2e72da
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ITGA2 CNTN6 PTPRF FHIP1A MOCOS HSPG2 RASSF7	1.48e-05	181	194	7	b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell	5'-Adult-LymphNode-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PTGDS CCL2 MXRA5 TENM4 ZFHX4 TENM3 CCDC181	1.48e-05	181	194	7	ab66a89f316b935d9ba1277426d976b1e9e39757
ToppCell	3'_v3-blood-Myeloid_Dendritic-pDC\|blood / Manually curated celltypes from each tissue	PTGDS NRP1 BRCA2 DMD FHIP1A SRPK3 HERPUD1	1.48e-05	181	194	7	66d890a105f955dca91d6e5e6c730d1a68ee9233
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 NRP1 GLI2 DMD MAMLD1 GRIN2A TENM3	1.54e-05	182	194	7	44764676ed3f51ba171ce63f669390392fa50a43
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 NRP1 GLI2 DMD MAMLD1 GRIN2A TENM3	1.54e-05	182	194	7	d82f59a3f930a840dde27dc6ab024f227a26d446
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-Late_airway_progenitor\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	CELF4 TBC1D2 FREM2 ODAM DMD CPM PKP3	1.59e-05	183	194	7	0cea883a8a79fc58abcb26b08bf5db9d3d60f7d4
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ITGA2 CNTN6 PTPRF FHIP1A MOCOS HSPG2 RASSF7	1.65e-05	184	194	7	42ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GLI2 DMD MAMLD1 COL5A3 GRIN2A PKNOX2 TENM3	1.65e-05	184	194	7	c5436a8e45f471b8d1301abbe9c7879204537f52
ToppCell	PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	GBP6 ITGA2 FREM2 VWA2 FHIP1A FRMPD2 CPM	1.65e-05	184	194	7	fa4915b0498f3069fd5ef497286445528f75187e
ToppCell	pdx-Tumor_cells-T0\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ABCA1 CDHR3 DMD TENM3 KIAA1755 PUM1 NFAT5	1.71e-05	185	194	7	1d874608aa2062024323512f68889219471b2f00
ToppCell	PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ITGA2 FREM2 PTPRF VWA2 FHIP1A CPM RASSF7	1.83e-05	187	194	7	db2974e2e87ac9f1c2407a371d5ed89af09fc9b7
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TBC1D2 CNTN6 FHIP1A HSPG2 CPM FREM3 ICAM5	1.83e-05	187	194	7	4ae7465174e0295d2c3b614b321a3b2f514dd22a
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TBC1D2 CNTN6 PTPRF FHIP1A HSPG2 CPM ICAM5	1.89e-05	188	194	7	eea652bab161f19148a883e7e3fe2523b36b3cea
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA1 INSRR JUN PTPRF PRRC2B TENM3 HERPUD1	1.89e-05	188	194	7	a91443aa8fa8fa87f7501c59219daa0305bd0bbf
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 GLI2 DMD MAMLD1 GRIN2A PKNOX2 TENM3	1.96e-05	189	194	7	71397e993a77d70b2eeede240bdfc7660b558987
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 GLI2 DMD MAMLD1 GRIN2A PKNOX2 TENM3	1.96e-05	189	194	7	4eea4759520c312bd17a681034d8074e47093d2b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 NRP1 GLI2 MAMLD1 PKNOX2 TENM3 ENAH	2.03e-05	190	194	7	2306aa9dbeaef3be8484a5b236605de23cd75d4c
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	ZNF174 UBQLN4 ITPK1 CCL2 SEC23A MORC4 MYBL1	2.03e-05	190	194	7	651a1d3ae286e40f9d9f60e438211c6148d24143
ToppCell	Monocytes-Tissue-resident_macrophages\|World / Immune cells in Kidney/Urine in Lupus Nephritis	CTTNBP2NL FCGBP LY86 FN1 DSC2 CPM HAMP	2.03e-05	190	194	7	07215e8f292cb54c670037aaf28393cddbe5548c
ToppCell	368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)\|368C / Donor, Lineage, Cell class and subclass (all cells)	PLD3 FCGBP CCL2 CCL13 LY86 DSC2 CPM	2.03e-05	190	194	7	cbba3d94a4c3e0b0d14f3b7c60dba5d6e097c5e3
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 NRP1 GLI2 MAMLD1 PKNOX2 TENM3 ENAH	2.03e-05	190	194	7	1f83f7f24288a3b9ab33c2e113e845dba96adc8a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 NRP1 GLI2 DMD MAMLD1 GRIN2A TENM3	2.10e-05	191	194	7	a6c57627077fa980b7ec1d3894b5f31bfb11b738
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 NRP1 GLI2 DMD MAMLD1 GRIN2A TENM3	2.10e-05	191	194	7	8f6d592edc32fdb901af30501d4360512334e8c2
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-mesothelial_cell\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PTGDS CNTN6 PTPRF DMD GRIN2A RASSF7 MMEL1	2.17e-05	192	194	7	2f539653a20006bef814e6b4acd1023d6fdad5c6
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NRP1 GLI2 DMD MAMLD1 GRIN2A ATP10A TENM3	2.24e-05	193	194	7	f1199518c3626fd29bfce65070dd21a660671213
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LXN FREM2 JUN DMD FLNA FN1 ENAH	2.24e-05	193	194	7	a402e736440684ebe123673b6b0c6fcd8fa057b2
ToppCell	PCW_05-06-Epithelial-Epithelial_airway\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	FREM2 PTPRF DMD FHIP1A CPM RASSF7 PKP3	2.24e-05	193	194	7	af6ec2c2ba92aef3e41531c3c7215b3300437bd9
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NRP1 GLI2 DMD MAMLD1 GRIN2A PKNOX2 TENM3	2.32e-05	194	194	7	81713e0409e8be695ba5dfdc67a997b33435dd9e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NRP1 GLI2 DMD MAMLD1 GRIN2A PKNOX2 TENM3	2.32e-05	194	194	7	627cffe2d448e74fc5df92e74e5b922a73304137
ToppCell	PCW_05-06-Epithelial-Epithelial_alveolar-distal\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ITGA2 FREM2 PTPRF FHIP1A CPM RASSF7 PKP3	2.32e-05	194	194	7	acd5ba9a097595d4caab4f05440531c65a4aa7bc
ToppCell	18-Airway-Epithelial-Bud_tip_adjacent\|Airway / Age, Tissue, Lineage and Cell class	TBC1D2 FREM2 ODAM DMD CPM FREM3 RASSF7	2.32e-05	194	194	7	b45f1e80074a19245bc5dc4b3a583419a1904404
ToppCell	PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ITGA2 FREM2 PTPRF ODAM FHIP1A CPM RASSF7	2.40e-05	195	194	7	98dd3b7d5ef587825dac052dea4d4ff883f6d4d6
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA1 INSRR KMT2C PTPRF TULP4 PRRC2C DYNC1H1	2.40e-05	195	194	7	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	PCW_10-12-Epithelial-Epithelial_airway-epi_intermediate_(1)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CNTN6 FREM2 PTPRF DMD FHIP1A CPM RASSF7	2.40e-05	195	194	7	d67a2b489c29bfd575751c13d2a5b1efdec5240a
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZHX3 ZBTB20 PRRC2C IPO7 COL5A3 RELA PUM1	2.48e-05	196	194	7	66d76249bd2770cdddff2c1fe59a016e95da2124
ToppCell	wk_20-22-Epithelial-Distal_epithelial\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	TBC1D2 PLD3 FREM2 ODAM CPM RASSF7 PKP3	2.48e-05	196	194	7	cd507ee2baf4f52d6498811b3510d3164b56311f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GLI2 DMD FLNA FN1 ATP10A TENM3 ENAH	2.48e-05	196	194	7	fa445f4240c521cf04eb2e2f79a5c55fda31209a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GLI2 DMD FLNA FN1 ATP10A TENM3 ENAH	2.48e-05	196	194	7	802f61e78a9a1030a86c4a980c398a73cd4d1574
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZHX3 ZBTB20 PRRC2C IPO7 COL5A3 RELA PUM1	2.48e-05	196	194	7	9bd4c146fc7555e32adfa393b3a07846eb826d25
ToppCell	mLN-B_cell-B_cell_cycling\|mLN / Region, Cell class and subclass	NEB NKX6-3 MED12L DMD POU2F1 ORC1 MYBL1	2.56e-05	197	194	7	806dddcca85c82bd642008d930c8db16b613d88e
ToppCell	MS-mono1\|MS / Condition, Cell_class and T cell subcluster	PLD3 CTTNBP2NL FCGBP LY86 CPM HAMP HERPUD1	2.56e-05	197	194	7	32be48ee2a1397ed8f1ee8e60067dd9a96bece39
ToppCell	MS-mono1-\|MS / Condition, Cell_class and T cell subcluster	PLD3 CTTNBP2NL FCGBP LY86 CPM HAMP HERPUD1	2.56e-05	197	194	7	4b038a193ecc1df65bcb608091c513ddafd6c818
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GLI2 CCL2 DMD FN1 MAMLD1 ATP10A TENM3	2.56e-05	197	194	7	9b480f9c799a244bfee64487abd8a1bf07c9a3a2
ToppCell	343B-Endothelial_cells-Endothelial-A_(Artery)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	CDH23 LXN PTGDS SEC23A HSPG2 FLNA PKNOX2	2.56e-05	197	194	7	ec92d60f802c9d4bdf9877bed5c0a91a5a5ed5d0
ToppCell	343B-Endothelial_cells-Endothelial-A_(Artery)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	CDH23 LXN PTGDS SEC23A HSPG2 FLNA PKNOX2	2.56e-05	197	194	7	7bec9c1bc8851064eb229324493b47a31201c83c
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG\|World / Primary Cells by Cluster	CDH23 ITGA2 JUN FLNA COL5A3 GRIN2A ZFHX4	2.56e-05	197	194	7	61749ccafeb938c310cff1de5ff924a1c794325a
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	GLI2 MXRA5 FN1 PKNOX2 TENM4 TENM3 ENAH	2.56e-05	197	194	7	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG-25\|World / Primary Cells by Cluster	CDH23 ITGA2 JUN FLNA COL5A3 GRIN2A ZFHX4	2.56e-05	197	194	7	9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6
ToppCell	mLN-(2)_B_cell-(24)_B_cell_cycling\|mLN / shred on region, Cell_type, and subtype	NEB NKX6-3 MED12L DMD POU2F1 ORC1 MYBL1	2.56e-05	197	194	7	70fff2d6723f259e18e7a21d22dc46d71f0759ce
ToppCell	15-Distal-Epithelial\|Distal / Age, Tissue, Lineage and Cell class	FREM2 PTPRF ODAM DMD CPM RASSF7 PKP3	2.56e-05	197	194	7	9fbd1abf050b364155a67962a9731118304f72fb
ToppCell	11.5-Airway-Epithelial\|Airway / Age, Tissue, Lineage and Cell class	FREM2 PTPRF DMD CPM RASSF7 PCDH20 PKP3	2.56e-05	197	194	7	e671af1b69566d97afe97f1a959a07b6f4c05620
ToppCell	wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-stalk_late\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	TBC1D2 FREM2 PTPRF ODAM DMD CPM RASSF7	2.64e-05	198	194	7	1851b7f4198b42c21c934e2fbda39dbd65e2625c
ToppCell	wk_15-18-Epithelial-Airway_epithelial_progenitor\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	TBC1D2 PLD3 FREM2 PTPRF DMD CPM RASSF7	2.64e-05	198	194	7	c477405b093f4e5374e57bcacf1fb204a0f7eb3b
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_macrophage\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ABCA1 PLD3 CTTNBP2NL NRP1 FCGBP DSC2 CPM	2.73e-05	199	194	7	b827dd8a249f904a0ff930a6c4d3b00fb7bc6fb1
ToppCell	Fibroblasts-HLA-DRA_high_Fibroblasts\|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	PTGDS NRP1 JUN CCL2 MXRA5 PKNOX2 KIAA1755	2.73e-05	199	194	7	fcbb3a9c0f4c5b4c1f09db24b9f50cc1166fa43b
ToppCell	ILEUM-non-inflamed-(8)_Fibroblast\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	PTGDS TSC22D1 CCL2 CCL13 MXRA5 FN1 ENAH	2.73e-05	199	194	7	6a0df9a2f30480043f9c1d7fbdede17eb0910cac
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ABCA1 PLD3 CTTNBP2NL NRP1 FCGBP DSC2 CPM	2.73e-05	199	194	7	c0dcdda30485bb920d3706dcfb06f11b76b6ea37
ToppCell	Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intravascular\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA1 PLD3 CCL13 LY86 ALOX5 DSC2 CPM	2.82e-05	200	194	7	ea039de8bd8b325845ce361f84e600c6dad922ed
ToppCell	Parenchymal-10x5prime-Stromal-Peri/Epineurial_\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CELF4 ZBTB20 PTGDS CES2 MAMLD1 DUSP15 CHRD	2.82e-05	200	194	7	4c3c11dd5e71ebc3d62264eeaeb71a850b149779
ToppCell	367C-Myeloid-Macrophage-SPP1+_Macrophage\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	DAD1 PLD3 CCL2 CCL13 FLNA FN1 HAMP	2.82e-05	200	194	7	d0ffd0d403a335c477c1b72391078b1595d9630c
ToppCell	wk_08-11-Epithelial\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	ITGA2 PLD3 FREM2 PTPRF CPM RASSF7 PKP3	2.82e-05	200	194	7	445fc7995ffc440c6256a6aab0bbf33fb0fea028
ToppCell	Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intravascular\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA1 PLD3 CCL13 LY86 ALOX5 DSC2 CPM	2.82e-05	200	194	7	77a68e8fd97a3f3467d25032067fd7ad52ab8522
Drug	Propantheline bromide [50-34-0]; Up 200; 9uM; MCF7; HT_HG-U133A	ZHX3 TBC1D2 CEACAM7 PTGDS JUN ADPRM CDYL MXRA5 TENM3 PUM1 ZMYM5	7.87e-07	194	191	11	4798_UP
Drug	Allopurinol	SREBF1 JUN CCL2 FN1 RELA GRIN2A NFAT5	1.34e-06	66	191	7	ctd:D000493
Drug	aptiganel	ITGA2 JUN GRIN2A GRIN2B ZACN	3.31e-06	28	191	5	CID000060839
Drug	arachidonyl trifluoromethyl ketone; Down 200; 10uM; MCF7; HG-U133A	ZBTB20 LRRC49 GCKR NRP1 NRSN2 CDYL FN1 RBL2 MAU2 HERPUD1	6.18e-06	195	191	10	327_DN
Drug	Triflusal [322-79-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A	JUN PTPRF RECQL5 CDYL DSC2 MAMLD1 GPR107 GTF2A1 MAPKBP1 NFAT5	6.18e-06	195	191	10	7451_DN
Drug	Nabumetone [42924-53-8]; Up 200; 17.6uM; HL60; HT_HG-U133A	ABCA1 PTGDS ITPK1 NRP1 RECQL5 FAM135A ALOX5 VHL FN1 ATP10A	6.46e-06	196	191	10	3108_UP
Drug	Ajmaline [4360-12-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A	ZHX3 PTGDS JUN NRSN2 ADPRM RECQL5 DSC2 DDX52 ATP10A PCNX1	6.76e-06	197	191	10	7484_UP
Drug	0316684-0000 [391209-55-5]; Up 200; 10uM; MCF7; HT_HG-U133A	ZHX3 CES2 ITPK1 PRMT2 CDYL HSPG2 OPA3 GPR107 GLCE NFAT5	6.76e-06	197	191	10	7093_UP
Drug	lipoteichoic acid	JUN CCL2 RELA GRIN2A GRIN2B	1.20e-05	36	191	5	ctd:C009900
Drug	diphenyliodonium	JUN CCL2 FN1 RELA	1.34e-05	18	191	4	ctd:C031291
Drug	ginsenoside Rc	RBL2 GRIN2A GRIN2B ZACN	2.09e-05	20	191	4	CID000100018
Drug	trypanothione disulfide	SREBF1 ITGA2 CCL2 CCL13 LY86 FN1 ICAM3 INTS5	2.46e-05	140	191	8	CID000115098
Drug	Etofenamate [30544-47-9]; Up 200; 10.8uM; PC3; HT_HG-U133A	ZHX3 DCHS2 ABCA1 CEACAM7 PTGDS CCL2 GTF2A1 HAMP CCDC181	3.84e-05	193	191	9	3989_UP
Drug	LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A	ZNF174 JUN CDYL SEC23A FN1 OPA3 RNF126 ORC1 GTF2A1	3.84e-05	193	191	9	6956_DN
Drug	Piroxicam [36322-90-4]; Up 200; 12uM; PC3; HT_HG-U133A	ZBTB20 ITGA2 GLI2 HELZ DSC2 POU2F1 ICAM5 PKP3 NFAT5	4.16e-05	195	191	9	2089_UP
Drug	nordihydroguaiaretic acid; Down 200; 1uM; HL60; HT_HG-U133A	RFK ZNF174 ADPRM CDYL PRRC2B FN1 RNF126 RASSF7 INTS5	4.33e-05	196	191	9	1164_DN
Drug	Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A	MAML1 ITPK1 JUN NRSN2 DDX52 OPA3 ZFHX4 PCNX1 NFAT5	4.33e-05	196	191	9	3416_UP
Drug	Sulfameter [651-06-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A	ZHX3 CEACAM7 NEB ITPK1 RECQL5 HSPG2 FN1 MAPKBP1 NFAT5	4.50e-05	197	191	9	3453_UP
Drug	Adiphenine hydrochloride [50-42-0]; Up 200; 11.4uM; PC3; HT_HG-U133A	RFK ZNF174 TAB2 ADPRM PRMT2 CPM RNF126 GPR107 RRN3	4.68e-05	198	191	9	7279_UP
Drug	Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; PC3; HT_HG-U133A	SP4 MAML1 JUN PRMT2 FAM135A ATP10A GTF2A1 SAYSD1 NFAT5	4.68e-05	198	191	9	4343_UP
Drug	Fenbendazole [43210-67-9]; Down 200; 13.4uM; PC3; HT_HG-U133A	ABCA1 ZBTB20 ZNF174 NRP1 RECQL5 PRMT2 HSPG2 OPA3 CPM	4.68e-05	198	191	9	3805_DN
Drug	heme arginate	JUN CCL2 RELA	4.70e-05	9	191	3	ctd:C048849
Disease	Kidney Failure, Chronic	ABCA1 SREBF1 CCL2 RELA HAMP	1.17e-05	48	182	5	C0022661
Disease	placental insufficiency (biomarker_via_orthology)	ITGA2 GRIN2A GRIN2B	1.26e-05	8	182	3	DOID:3891 (biomarker_via_orthology)
Disease	cognitive disorder (biomarker_via_orthology)	IRAK1 GRIN2A GRIN2B	1.26e-05	8	182	3	DOID:1561 (biomarker_via_orthology)
Disease	Silicosis	JUN CCL2 CPM	1.89e-05	9	182	3	C0037116
Disease	amyotrophic lateral sclerosis type 15 (implicated_via_orthology)	UBQLN4 UBQLN1	1.13e-04	3	182	2	DOID:0060206 (implicated_via_orthology)
Disease	tubulointerstitial nephritis antigen-like measurement	GCKR HSPG2	1.13e-04	3	182	2	EFO_0803197
Disease	Manic	SP4 ITIH1 CCL2 GRIN2A TENM4	1.24e-04	78	182	5	C0338831
Disease	Neoplasm Invasiveness	ITPK1 CCL2 DMD ALOX5 UBQLN1 FN1 RELA	1.53e-04	184	182	7	C0027626
Disease	HMG CoA reductase inhibitor use measurement	ZHX3 ABCA1 GCKR BRCA2 DDX56 PCNX1 HERPUD1	1.80e-04	189	182	7	EFO_0009932
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	ABCA1 GCKR CES2 DDX56 MSL2 HERPUD1	2.80e-04	144	182	6	EFO_0004611, EFO_0020943
Disease	arrhythmogenic right ventricular cardiomyopathy (implicated_via_orthology)	DSC1 DSC2	3.74e-04	5	182	2	DOID:0050431 (implicated_via_orthology)
Disease	desmocollin-2 measurement	DSC1 DSC2	3.74e-04	5	182	2	EFO_0021936
Disease	palmitoleoyl-linoleoyl-glycerol (16:1/18:2) [1] measurement	GCKR MAU2	3.74e-04	5	182	2	EFO_0800504
Disease	Duchenne and Becker Muscular Dystrophy	CCL2 DMD	3.74e-04	5	182	2	C3542021
Disease	Becker Muscular Dystrophy	CCL2 DMD	3.74e-04	5	182	2	C0917713
Disease	cholesterol to total lipids in large LDL percentage	ABCA1 GCKR RRN3 HERPUD1	4.00e-04	56	182	4	EFO_0022235
Disease	Ureteral obstruction	CCL2 FN1 RELA	4.25e-04	24	182	3	C0041956
Disease	Intellectual Disability	HIVEP2 QRICH1 ZNF462 KMT2C MED12L DYNC1H1 IQSEC3 SIN3A GRIN2B PUM1	4.87e-04	447	182	10	C3714756
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	ABCA1 GCKR CES2 DDX56 RRN3 NFAT5 HERPUD1	5.16e-04	225	182	7	EFO_0008317, EFO_0020947
Disease	myocarditis (is_marker_for)	CCL2 HAMP	5.58e-04	6	182	2	DOID:820 (is_marker_for)
Disease	diabetic angiopathy (implicated_via_orthology)	CCL2 FN1	5.58e-04	6	182	2	DOID:11713 (implicated_via_orthology)
Disease	age related macular degeneration (implicated_via_orthology)	CCL2 CCL13	5.58e-04	6	182	2	DOID:10871 (implicated_via_orthology)
Disease	Muscular Dystrophy, Duchenne	CCL2 DMD	5.58e-04	6	182	2	C0013264
Disease	bipolar disorder (is_implicated_in)	CCL2 GRIN2A GRIN2B	7.49e-04	29	182	3	DOID:3312 (is_implicated_in)
Disease	neuropilin-1 measurement	GCKR NRP1	7.79e-04	7	182	2	EFO_0020603
Disease	ductal carcinoma in situ (is_implicated_in)	BRCA2 RELA	7.79e-04	7	182	2	DOID:0060074 (is_implicated_in)
Disease	Tourette syndrome, bipolar disorder	MAU2 TENM4	7.79e-04	7	182	2	EFO_0004895, MONDO_0004985
Disease	Bipolar Disorder	SP4 GPR50 PTGDS ITIH1 CNTN6 BRCA2 GRIN2A GRIN2B TENM4 CDH17	8.02e-04	477	182	10	C0005586
Disease	total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer	ZHX3 GCKR ITPK1 HERPUD1	8.86e-04	69	182	4	EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992
Disease	low density lipoprotein cholesterol measurement, phospholipid measurement	ABCA1 GCKR BRCA2 DDX56 HERPUD1	9.08e-04	120	182	5	EFO_0004611, EFO_0004639
Disease	Severe Congenital Microcephaly	DYNC1H1 SIN3A ORC1	9.14e-04	31	182	3	C3853041
Disease	cholesteryl esters to total lipids in large LDL percentage	ABCA1 GCKR HERPUD1	9.14e-04	31	182	3	EFO_0022249
Disease	Manic Disorder	SP4 ITIH1 GRIN2A TENM4	9.86e-04	71	182	4	C0024713
Disease	heart conduction disease (implicated_via_orthology)	SREBF1 MMEL1 PYGO1	1.00e-03	32	182	3	DOID:10273 (implicated_via_orthology)
Disease	Myopathies, Nemaline	NEB SRPK3	1.03e-03	8	182	2	C0206157
Disease	NRF2 measurement	CDYL GRIN2B	1.03e-03	8	182	2	EFO_0009794
Disease	Microlissencephaly	DYNC1H1 SIN3A ORC1	1.10e-03	33	182	3	C1956147
Disease	cholesteryl ester measurement, low density lipoprotein cholesterol measurement	ABCA1 GCKR BRCA2 DDX56 HERPUD1	1.13e-03	126	182	5	EFO_0004611, EFO_0010351
Disease	coronary artery disease	ZHX3 ABCA1 HIVEP2 ZBTB20 SREBF1 TAB2 QRICH1 ITPK1 NRP1 FN1 PNLIPRP2 MSL2 RBPMS2 SAYSD1 NFAT5 HERPUD1 CDH17	1.21e-03	1194	182	17	EFO_0001645
Disease	triacylglycerol 52:5 measurement	GCKR MAU2 TENM3	1.31e-03	35	182	3	EFO_0010417
Disease	serine measurement	GCKR DYNC1H1 GRIN2A	1.31e-03	35	182	3	EFO_0009774
Disease	corneodesmosin measurement	CCL2 CCL13	1.32e-03	9	182	2	EFO_0801499
Disease	apolipoprotein A-V measurement	GCKR HERPUD1	1.32e-03	9	182	2	EFO_0801387
Disease	monounsaturated fatty acids; 16:1, 18:1 measurement	GCKR MAU2 RRN3 HERPUD1	1.40e-03	78	182	4	EFO_0022187
Disease	Alcoholic Intoxication, Chronic	CNTN6 GLI2 GRIN2A GRIN2B PKNOX2 HAMP HERPUD1	1.43e-03	268	182	7	C0001973
Disease	free cholesterol in large HDL measurement	ABCA1 GCKR RRN3 HERPUD1	1.47e-03	79	182	4	EFO_0022157
Disease	Depression, Bipolar	SP4 ITIH1 GRIN2A TENM4	1.47e-03	79	182	4	C0005587
Disease	cholesterol in large HDL measurement	ABCA1 GCKR RRN3 HERPUD1	1.54e-03	80	182	4	EFO_0021900
Disease	Asthma, Occupational	TENM3 CDH17	1.65e-03	10	182	2	C0264423
Disease	prostate adenocarcinoma (is_marker_for)	JUN RELA	1.65e-03	10	182	2	DOID:2526 (is_marker_for)
Disease	triacylglycerol 54:1 measurement	MAU2 ZFHX4	1.65e-03	10	182	2	EFO_0010419
Disease	1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) measurement	GCKR HERPUD1	1.65e-03	10	182	2	EFO_0800464
Disease	level of Sterol ester (27:1/18:3) in blood serum	GCKR MAU2	1.65e-03	10	182	2	OBA_2045193
Disease	level of phosphatidylcholine	GCKR HERPUD1	1.65e-03	10	182	2	OBA_2040179
Disease	Allodynia	ITGA2 CCL2 ALOX5 GRIN2B	1.84e-03	84	182	4	C0458247
Disease	Mechanical Allodynia	ITGA2 CCL2 ALOX5 GRIN2B	1.84e-03	84	182	4	C2936719
Disease	Hyperalgesia, Secondary	ITGA2 CCL2 ALOX5 GRIN2B	1.84e-03	84	182	4	C0751212
Disease	Hyperalgesia, Primary	ITGA2 CCL2 ALOX5 GRIN2B	1.84e-03	84	182	4	C0751211
Disease	Hyperalgesia, Thermal	ITGA2 CCL2 ALOX5 GRIN2B	1.84e-03	84	182	4	C0751214
Disease	Tactile Allodynia	ITGA2 CCL2 ALOX5 GRIN2B	1.84e-03	84	182	4	C0751213
Disease	Hyperalgesia	ITGA2 CCL2 ALOX5 GRIN2B	1.84e-03	84	182	4	C0020429
Disease	lipoprotein-associated phospholipase A(2) measurement	GCKR GLCE HERPUD1	1.93e-03	40	182	3	EFO_0004746
Disease	hyperhomocysteinemia (implicated_via_orthology)	GRIN2A GRIN2B	2.01e-03	11	182	2	DOID:9279 (implicated_via_orthology)
Disease	vascular dementia (is_marker_for)	GRIN2A GRIN2B	2.01e-03	11	182	2	DOID:8725 (is_marker_for)
Disease	asparagine measurement	GCKR CNTN6 A2ML1	2.07e-03	41	182	3	EFO_0009766
Disease	Nodular glomerulosclerosis	CCL2 FN1 RELA	2.07e-03	41	182	3	C0017667
Disease	Secondary Biliary Cholangitis	ICAM3 RELA MMEL1	2.22e-03	42	182	3	C0238065
Disease	Biliary cirrhosis	ICAM3 RELA MMEL1	2.22e-03	42	182	3	C0023892
Disease	Biliary Cirrhosis, Primary, 1	ICAM3 RELA MMEL1	2.22e-03	42	182	3	C4551595
Disease	Tumoral calcinosis	CCL2 DMD LY86	2.22e-03	42	182	3	C0263628
Disease	Calcinosis	CCL2 DMD LY86	2.22e-03	42	182	3	C0006663
Disease	Microcalcification	CCL2 DMD LY86	2.22e-03	42	182	3	C0521174
Disease	pulmonary tuberculosis (is_implicated_in)	JUN CCL2 ALOX5	2.22e-03	42	182	3	DOID:2957 (is_implicated_in)
Disease	Reperfusion Injury	JUN CCL2 ALOX5 RELA	2.27e-03	89	182	4	C0035126
Disease	resting heart rate	ZHX3 SREBF1 MAML1 GCKR KIAA1755	2.36e-03	149	182	5	EFO_0004351
Disease	frontotemporal dementia (implicated_via_orthology)	UBQLN4 UBQLN1	2.40e-03	12	182	2	DOID:9255 (implicated_via_orthology)
Disease	Diabetic Nephropathy	CCL2 FN1 RELA	2.54e-03	44	182	3	C0011881
Disease	low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	ABCA1 GCKR CES2 DDX56 HERPUD1	2.65e-03	153	182	5	EFO_0004611, EFO_0020944
Disease	Malignant neoplasm of kidney	BRCA2 VHL HAMP	2.71e-03	45	182	3	C0740457
Disease	intercellular adhesion molecule 5 measurement	ICAM3 ICAM5	2.82e-03	13	182	2	EFO_0008164
Disease	iron deficiency anemia (biomarker_via_orthology)	FN1 HAMP	2.82e-03	13	182	2	DOID:11758 (biomarker_via_orthology)
Disease	level of Phosphatidylcholine (16:0_18:3) in blood serum	GCKR HERPUD1	2.82e-03	13	182	2	OBA_2045072
Disease	disease progression measurement, Crohn's disease	CDHR3 DAD1 NRP1	3.07e-03	47	182	3	EFO_0000384, EFO_0008336
Disease	Gastrointestinal Stromal Sarcoma	GLI2 DMD C2CD3	3.07e-03	47	182	3	C3179349
Disease	Primary biliary cirrhosis	ICAM3 RELA MMEL1	3.07e-03	47	182	3	C0008312
Disease	end stage renal disease (biomarker_via_orthology)	CCL2 RELA HAMP	3.07e-03	47	182	3	DOID:783 (biomarker_via_orthology)
Disease	phosphoglycerides measurement	ABCA1 GCKR HERPUD1	3.26e-03	48	182	3	EFO_0022291
Disease	skin melanoma (is_implicated_in)	BRCA2 CCL2	3.28e-03	14	182	2	DOID:8923 (is_implicated_in)
Disease	Saldino-Noonan Syndrome	DYNC2I1 C2CD3	3.28e-03	14	182	2	C0036069
Disease	low density lipoprotein cholesterol measurement, alcohol consumption measurement	ZHX3 ABCA1 DDX56 HERPUD1	3.34e-03	99	182	4	EFO_0004611, EFO_0007878
Disease	cholesteryl ester measurement, high density lipoprotein cholesterol measurement	ABCA1 GCKR CES2 ALOX5 MSL2 MAPKBP1 HERPUD1	3.35e-03	312	182	7	EFO_0004612, EFO_0010351
Disease	Schizophrenia	SP4 ABCA1 GPR50 SREBF1 ITIH1 JUN CCL2 NPAS1 RELA GRIN2A GRIN2B PKNOX2 TENM4	3.42e-03	883	182	13	C0036341
Disease	developmental disorder of mental health (implicated_via_orthology)	SIN3A GRIN2A GRIN2B	3.45e-03	49	182	3	DOID:0060037 (implicated_via_orthology)
Disease	Adenoid Cystic Carcinoma	INSRR CNTN6 KMT2C MYBL1	3.47e-03	100	182	4	C0010606
Disease	epilepsy (implicated_via_orthology)	CDYL DYNC1H1 GRIN2A GRIN2B SLC13A2	3.48e-03	163	182	5	DOID:1826 (implicated_via_orthology)
Disease	lifestyle measurement	CELF4 HIVEP2 ZBTB20 HELZ FHIP1A RBL2	3.48e-03	235	182	6	EFO_0010724
Disease	total cholesterol measurement, high density lipoprotein cholesterol measurement	ABCA1 GCKR CES2 ALOX5 MSL2 MAPKBP1 HERPUD1	3.53e-03	315	182	7	EFO_0004574, EFO_0004612
Disease	obesity (is_marker_for)	PTPRF CCL2 VHL RELA	3.59e-03	101	182	4	DOID:9970 (is_marker_for)
Disease	Gastrointestinal Stromal Tumors	GLI2 DMD C2CD3	3.66e-03	50	182	3	C0238198
Disease	polyunsaturated fatty acids to total fatty acids percentage	GCKR RRN3 HERPUD1	3.66e-03	50	182	3	EFO_0022303

Protein segments in the cluster

Peptide	Gene	Start	Entry
ELTAGNNVENQVPPR	CTTNBP2NL	361	Q9P2B4
VQGTDLPDPIATFQQ	DDX52	151	Q9Y2R4
QQKAIQPQAAQGPAA	EP400	2976	Q96L91
QPQAAQGPAAVQQKI	EP400	2981	Q96L91
AQVFGNQLIPPNAQV	AGK	46	Q53H12
HFQSLQEGQPPQVLS	PRMT2	346	P55345
LGLNIAPFINQFQVP	PRMT9	721	Q6P2P2
FGVQTQPQPQSLLQA	CCAR1	236	Q8IX12
AFNPQGLAQPDALNV	CCL13	16	Q99616
NTQALPPSQEVNDAI	ABCA1	1541	O95477
FSPSQQLPGAEVELQ	A2ML1	566	A8K2U0
EPQSQGNSQVLLDAP	ABCF3	76	Q9NUQ8
LNSPQGLSEPQFVQF	ADPRM	196	Q3LIE5
QQKAPPVVGGFNSNV	GLCE	81	O94923
PNSAQTNIDVVPFNV	CEACAM7	31	Q14002
DICNQLQQPGFPVTV	CEP78	411	Q5JTW2
QAPIGGDFPAVQKQN	DMD	2831	P11532
SINGVENQDQQEPKP	CDC14C	371	A4D256
LVNVNDINDNVPTFP	CDH23	1731	Q9H251
ENSLGPFPLFLQQVQ	DSC2	146	Q02487
LLNFVPAVNAFQPGL	ATP10A	96	O60312
RQALAVNQGQPPFEG	C17orf113	86	A0A1B0GUU1
NALNGIRFDPENPQT	RBPMS2	86	Q6ZRY4
NLQQFIQQTGAALPP	RASSF7	291	Q02833
PTQPGALNQRQVQFS	HSPG2	651	P98160
QVQIQGQAPQSAAPS	QRICH1	136	Q2TAL8
PISADQQGFVQPSLE	QRICH2	376	Q9H0J4
EKVLGQSQEPNVNPA	GPR107	151	Q5VW38
ANQNAAPQVVVNPGA	HERPUD1	226	Q15011
APQVVVNPGANQNLR	HERPUD1	231	Q15011
KQAAPAENEAPQTQG	NPAS1	446	Q99742
VPENNQPGASIAQVS	PCDHGB7	461	Q9Y5F8
FSISNPAPQQFQGII	KIAA1107	886	Q9UPP5
PAPQQFQGIINLAFE	KIAA1107	891	Q9UPP5
QPLVNAVPVQNVSGE	RBL2	701	Q08999
QVFPERLAQGNPQQG	ATP23	26	Q9Y6H3
GQEQNPSSVPVQAQA	MAML1	576	Q92585
DINDNAPQFPVSQIS	PCDH20	201	Q8N6Y1
PQPQADLQALLQSGA	PLD3	171	Q8IV08
QINPQNKADFQGISP	DAD1	76	P61803
PLNQVANPNSAIFGG	EIF4H	221	Q15056
EGLNAIQPPCVVQNF	ITPK1	176	Q13572
FSPQSLPVQQHNILG	KMT2C	2541	Q8NEZ4
QQPGFFLQNQSLTPG	MED12L	1821	Q86YW9
QSFPNAGIPQESQRA	MAGEB17	51	A8MXT2
QQAQASGPQAEVPTL	MAGEL2	666	Q9UJ55
VNNPEFTIPQGEYQV	LY86	126	O95711
ANPATDFQLEVTPQN	ITIH1	736	P19827
NNTVAQVQSNPGPVA	ZBTB33	211	Q86T24
PEFQPATNSNEEIGQ	FSCB	196	Q5H9T9
FEPAQGNPNVAVARL	IZUMO1R	211	A6ND01
GAAGLAFPAQPQQQQ	JUN	191	P05412
EQNRTFQAGSPPQEA	KIAA1755	1116	Q5JYT7
LFAIVDQENNPALPG	AQP7P3	186	A6NL99
DNQPPEILNTGFTIQ	FREM2	826	Q5SZK8
PAGQNPDNQLAEVRN	GPR50	221	Q13585
QESQLPGPDQLQQFQ	DDX56	221	Q9NY93
QSDLGPVAKQQVSPN	DYNC2I1	986	Q8WVS4
ENVQPDQFDPLNSGN	FAM135A	591	Q9P2D6
NSLPNQVAFPEGEEQ	PCNX1	751	Q96RV3
VPGQPAQLQLNATEN	ICAM5	361	Q9UMF0
PQVLNQVSGQILPAF	IPO7	851	O95373
LQAQVQAAPPQGALE	OPA3	136	Q9H6K4
QVTDINDNPPAFSQA	PCDHGA9	441	Q9Y5G4
PTALDQQQQALPGTV	FAM205A	741	Q6ZU69
ENAQTVLPQASQGQP	FAM205A	1156	Q6ZU69
PTALDQQQQALPGTV	FAM205BP	471	Q63HN1
DFQPVPSIVGVNNNE	CES2	331	O00748
VGNTVFPILQTNNDP	METTL2B	191	Q6P1Q9
PFSGILQQQQQAQIP	ODAM	56	A1E959
LTIDPQGNPVVNFTL	LRRC49	496	Q8IUZ0
LIQGNNPRVQTSNFP	GBP6	206	Q6ZN66
FPQGNLAVVQQKPAF	GLI2	1166	P10070
SSPEVQGPIINFNVL	MOCOS	381	Q96EN8
PEQQLSPIFRNASGQ	NRSN2	166	Q9GZP1
VEQSNLVFNIQPAPG	OVOS2	1401	Q6IE36
SAQAAEQLQRGPNQP	IRAK1	571	P51617
SPNRNQIVFPAGILQ	MMEL1	576	Q495T6
FQNDGIVQPNPSVLI	HELZ	1141	P42694
QEPLQDQGQRSAAAP	IQSEC3	91	Q9UPP2
IPAAQEQPFIVSNQN	ITGA2	806	P17301
QPNLEATVSNGPFLQ	MSL2	291	Q9HCI7
LSQEQAQPPQQGLFQ	NFAT5	1196	O94916
VQNPEQEPLSQFLRG	POF1B	141	Q8WVV4
IQSANQPSDGQAPQV	NFYC	441	Q13952
LQPAQFIISQTPQGQ	POU2F1	201	P14859
AAAPGQPAQLQLNAT	ICAM3	351	P32942
VGNTVFPILQTNNDP	METTL2A	191	Q96IZ6
AQPQPAANQALAAGT	PUM1	46	Q14671
ISIQVLDVNDNPPNF	DCHS2	2651	Q6V1P9
NNTAVFLPVLVGFNP	GCKR	196	Q14397
NKPVLFQGNTNPTDV	NRP1	376	O14786
QANDVPPFQYIEVNG	ORC1	556	Q13415
TVQAAANIIVQAPPQ	PXDNL	406	A1KZ92
QDIASQGFLPPINNA	CCDC181	231	Q5TID7
QGFLPPINNANSTEN	CCDC181	236	Q5TID7
GTLLPNPVFSQNNEL	CUBN	3471	O60494
QAPQQTGAFPVQLFV	ERVK-5	616	Q9HDB9
EQQPPLSQVFQGISQ	ERVK-7	636	P63130
FGVNNPFLPQASRLQ	GNPTG	36	Q9UJJ9
QAEVQSVPINNGPLL	FHIP1A	671	Q05DH4
FSDQLPVQQENGQSP	C2CD3	676	Q4AC94
RQEIQNPNFTAPGQE	BRCA2	2341	P51587
KGQVFDQNGNPLPNV	CPM	316	P14384
EQSGAQQPPALQVER	CDYL	51	Q9Y232
TFIPQGLAQPDAINA	CCL2	16	P13500
RNPNNDQVFPNGTLA	FCGBP	3021	Q9Y6R7
DRNPNNDQVFPNGTL	FCGBP	4221	Q9Y6R7
VPNSPFQVTALAGDQ	FLNA	1731	P21333
FQVTALAGDQPSVQP	FLNA	1736	P21333
QVDAVPANGQTPIQR	FN1	1936	P02751
VQVTDVNEPPQFQGN	CDHR3	121	Q6ZTQ4
VNEPPQFQGNLAEGL	CDHR3	126	Q6ZTQ4
VNRALPGADPQDQQA	FRMPD2	261	Q68DX3
IANPNPGFRQQLEEF	DUSP15	121	Q9H1R2
SAFVDIQAEPQNRGP	REXO1L1P	146	Q8IX06
GPDNNSPIQIFTIQT	CNTN6	621	Q9UQ52
NSEVRNLNVPATFPN	CCP110	111	O43303
TQQPQFGPQSSILAN	MAMLD1	416	Q13495
QQLPVSSLFQGPENL	MAPKBP1	1371	O60336
GQVLPPLEAQEASFQ	INSRR	696	P14616
NSLGPFPQHVQQIQS	DSC1	146	Q08554
PQVTAVAQQNQGEVP	DYNC1H1	486	Q14204
EGSPHNNPTVQQIVQ	GOLGA6D	671	P0CG33
EIAVEQQLGAQPLPF	CPSF4	16	O95639
QLPAQVQNGPSQEEL	ENAH	126	Q8N8S7
QVQGITLTPQQDQAP	FAM186A	1141	A6NE01
AQALGIPLTPQQAQE	FAM186A	1176	A6NE01
QQAQELGIPLTPQQA	FAM186A	1186	A6NE01
QAQELGIPLTPQQAQ	FAM186A	1211	A6NE01
AQELGIPFTPQQAQA	FAM186A	1416	A6NE01
QAQELGIPLTPQQAQ	FAM186A	1511	A6NE01
AQELGIPLTPQQAQA	FAM186A	1596	A6NE01
GQEPSQIIFQFKANP	CDH17	41	Q12864
APNLVLQGQINSLFP	SLC13A2	241	Q13183
PVQFQAQNGPNTSLA	MAU2	596	Q9Y6X3
NNPQGIVVPASALQQ	PKNOX2	211	Q96KN3
GPPVSFQQAQAQAVL	COL5A3	456	P25940
QPHIVGIQSPDQQAA	ECSIT	261	Q9BQ95
PGNEQLNIENPSFTS	MYBL1	496	P10243
NENPNNFQLITGTEP	PNLIPRP2	61	P54317
KTQQGVPAQPADFQA	PTPRF	506	P10586
QVVDANDNPPAFTQA	PCDHGA1	231	Q9Y5H4
PLEAQNIPDNFGNVS	LXN	116	Q9BS40
DNQPPEVTNRGFAIL	FREM3	826	P0C091
AENFSQIPPQNASQV	PYGO1	181	Q9Y3Y4
QDPSNPAIIRQAAGN	RRN3	391	Q9NYV6
STPGQFQVIQVQNPS	SP4	146	Q02446
IIQAIPPQSFQLQSG	SP4	416	Q02446
VGPNNQPVSFQEIFE	SEPTIN14	321	Q6ZU15
LFQQEPQTAPAQVPQ	TAB2	121	Q9NYJ8
QNPLSGAQQFVAKDP	TADA1	116	Q96BN2
IQLNQIPGDENPIFL	ALOX5	326	P09917
QGTFLLNNTPLAQFP	NKX6-3	6	A6NJ46
AQAVIVPIVPFNQQN	MORC4	161	Q8TE76
QAAPEAQVSVQPNFQ	PTGDS	21	P41222
PTNGTVNNVAQEPVN	PRRC2C	1456	Q9Y520
TQLLNQFENTGPPPA	RNF126	191	Q9BV68
GTAPSLQNNQPVEFN	SIN3A	291	Q96ST3
PGRPQSQAEDTQQAL	SPATA31E1	661	Q6ZUB1
LAQFQAQLQTGSPPA	TSC22D1	1036	Q15714
PAVLSQLQQHLQGFP	INTS5	366	Q6P9B9
SVVLQPFFQNIQLPV	PLB1	971	Q6P1J6
VQNNNGRFVLPVSGP	OSCP1	191	Q8WVF1
FEVVNQHNAPIPQGG	SEC23A	461	Q15436
AGNPVDPLAQVTQLF	SREBF1	791	P36956
QVPQQGVQLPFVLGQ	SUPT20HL2	736	P0C7V6
GASNLLVNPLEPQNA	SRPK3	386	Q9UPE1
PQANGQPAAEAVFAN	CELF4	346	Q9BZC1
NVSAQEPGFAEVLPN	CHRD	351	Q9H2X0
QAQAQVPAKAPLAGQ	CNOT1	1021	A5YKK6
EQGTLNPTAQDPFQL	RECQL5	891	O94762
GPPLIQQNASEAEIF	PKP3	461	Q9Y446
QPAQTQAPLVLQVDG	GTF2A1	261	P52655
TQFAQQEPAVVLQPL	TULP4	1216	Q9NRJ4
NNNNSVGQAVDPPSL	ZXDB	651	P98169
PIQLQALQNAIAGDP	ZFHX4	3191	Q86UP3
PPDFLGQNQGILNVS	VSIG1	121	Q86XK7
SQLGEQELPDFQPQT	ZNF174	151	Q15697
AAPENNPINLANVIA	RPAP3	456	Q9H6T3
QALAGVNPQLQNPEV	UBQLN1	531	Q9UMX0
NVVIVEQPFPRNQAF	ZNF577	436	Q9BSK1
FVPSLNVDGQPIFAN	VHL	136	P40337
NVDGQPIFANITLPV	VHL	141	P40337
IDRDSGNPQPLVNAQ	TRPV2	141	Q9Y5S1
SDPQDLFNQIPELQG	VWA2	501	Q5GFL6
DSDVPFQIVVNQFPG	ZDBF2	1501	Q9HCK1
GQELLFPPQENVQDA	PRRC2B	826	Q5JSZ5
QDPSNPAIIRQAAGN	RRN3P1	16	Q2M238
GENQFVSQQPPVIGS	TENM4	1191	Q6N022
KGNGENQFISQQPPV	TENM3	1131	Q9P273
NNSFPADGQPVEQVV	USF3	481	Q68DE3
PTANFPEQVVDNLPA	RFK	26	Q969G6
ARAQPGLVQEAAQPQ	SAYSD1	61	Q9NPB0
FSLPQPLAGQQTQFV	ZBTB20	526	Q9HC78
PLAGQQTQFVTVSQP	ZBTB20	531	Q9HC78
PFTLESQVQIAGNPD	ZNF347	66	Q96SE7
VQESIQIPNNGSAPL	ZACN	46	Q401N2
TLVENVPPQVRNFNF	ZMYM5	536	Q9UJ78
LRQQQEGTNLPDVPN	ZNF462	276	Q96JM2
DPDNLPAQGQGNIII	TBC1D28	6	Q2M2D7
ANFQGSNPVLLEAPV	HIVEP2	521	P31629
ALGPAQTQVPEQRQF	UBR2	1091	Q8IWV8
TNNNPFQVPIEEQRG	RELA	136	Q04206
AGIAQFLSLQQQPPV	ZHX3	266	Q9H4I2
NVPLFAGNPQLQEQL	UBQLN4	426	Q9NRR5
GNSIDVSQLVNPAFP	ZP2	36	Q05996
AFQPENQINVPALDT	ZFC3H1	1316	O60293
VGVAAALQPFPALQN	TBC1D2	191	Q9BYX2
NPEALPSNTGEVNFQ	AGL	681	P35573
VFPQQTGQLAELQPQ	HAMP	26	P81172
VFGNNNIPEARNPVG	MXRA5	1701	Q9NR99
VVELPAAVQPQSFQQ	NACC1	66	Q96RE7
LVFNNSVPVQNPKGT	GRIN2A	611	Q12879
GLVFNNSVPVQNPKG	GRIN2B	611	Q13224
LAEQQAQFTPLADPP	NEB	246	P20929